ALGN Stock: Align Technology, Inc. Stock Price, Analysis & Insights
Get live algn stock price $134.84, comprehensive Align Technology, Inc. stock analysis, charts, news, and expert forecast. Real-time algn stock data and investment insights.
Loading chart...
Company Overview
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Company Information
- CEO
- Joseph M. Hogan
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 21200
Contact Information
- Website
- https://www.aligntech.com
- Address
- 410 North Scottsdale Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 26.1)
✓ Higher growth potential with elevated volatility (Beta: 1.87)
Business Model & Strategy
Align Technology, Inc. operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Joseph M. Hogan, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Align Technology, Inc. competes in the Medical - Devices within the broader Healthcare. With 9.8 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Align Technology, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Align Technology, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Align Technology, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Align Technology, Inc.
- ⚠Investors should consider how Align Technology, Inc. fits within their overall portfolio allocation
Market Cap
9.76B
P/E Ratio
26.13
Beta
1.87
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 9.76B market capitalization
- Trading Volume: 810.22K shares traded today
- Price Range: 52-week range of $122.00 - $246.19
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Align Technology, Inc.
Align Technology, Inc. (ALGN) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 9.76B, the company represents a significant player in its market. The stock is currently trading at $134.84 with a positivedaily change of 0.83%.
The company's 21200 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 26.13, beta of 1.87, and 52-week price range from $122.00 to $246.19when evaluating investment opportunities.
Why Invest in Align Technology, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Joseph M. Hogan
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.